4DCT oesophageal tumour delineation in SCOPE2 – how is radiotherapy quality assurance beneficial?
4DCT scanning in radiotherapy (RT) planning for distal oesophageal cancer enables the generation of patient specific target volumes by accounting for tumour motion. UK experience of this technique is increasing, facilitated by robust RT trial quality assurance (RTTQA) programmmes. We present outcome...
Main Authors: | Cox, S, Jones, G, Radhakrishna, G, Mukherjee, S, Hawkins, M, Crosby, T, Gwynne, S |
---|---|
Format: | Conference item |
Published: |
Elsevier
2018
|
Similar Items
-
NeoSCOPE RTTQA: pre-accrual and on-trial review of all patients in a UK oesophageal RT trial
by: Evans, E, et al.
Published: (2018) -
Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.
by: Gwynne, S, et al.
Published: (2013) -
Metal artefact reduction for accurate tumour delineation in radiotherapy
by: Kovacs, D, et al.
Published: (2017) -
The influence of dose distribution on treatment outcome in the SCOPE 1 oesophageal cancer trial
by: Carrington, E, et al.
Published: (2016) -
Oesophageal Chemoradiotherapy in the UK-Current Practice and Future Directions
by: Gwynne, S, et al.
Published: (2013)